Molecular Biology of the Ribonuclease A Gene Superfamily
核糖核酸酶 A 基因超家族的分子生物学
基本信息
- 批准号:7964509
- 负责人:
- 金额:$ 42.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Anti-Bacterial AgentsAntibodiesAntiviral AgentsBinding SitesBiochemistryBiologicalBiologyButyric AcidsCD34 geneCellsChemistryChickensConsensusConsensus SequenceDataDatabasesDiseaseEnzymesEosinophil cationic proteinEosinophil-Derived NeurotoxinEvolutionFamilyGATA2 transcription factorGenbankGenesGeneticGenetic TranscriptionGenomeHL60HematopoieticHomeostasisHost DefenseHumanImmunityInflammatoryJournalsLaboratoriesLegal patentLeukocytesManuscriptsMolecular BiologyMolecular CloningMutationNaturePancreatic ribonucleasePrimatesPublicationsRNA InterferenceRNase 2Recording of previous eventsReporter GenesReportingRibonucleasesRodentRoleStructureTimeVisitWorkchromatin immunoprecipitationeditorialeosinophilhuman GATA1 proteinnoveloverexpressionprogenitorpromoter
项目摘要
During this reporting period, we examined the roles of GATA-1 and GATA-2 in activating transcription of the secretory ribonuclease, the eosinophil-derived neurotoxin (EDN/RNase 2). Augmented expression of both GATA-1 and GATA-2 was detected in eosinophils and deletion or mutation of one or both of the two consensus GATA-binding sites in the extended 5' promoter of the EDN/RNase2 gene resulted in profound reduction in reporter gene activity. Antibody-augmented electrophoretic mobility shift and chromatin immunoprecipitation analyses indicate that GATA-1 and GATA-2 proteins bind to both functional GATA consensus sequences in the EDN promoter. Interestingly, RNA silencing of GATA-1 alone had no impact on EDN/RNase2 expression; silencing of GATA-2 resulted in diminished expression of EDN, and also diminished expression of GATA-1 in both butyric acid-induced HL-60 clone 15 cells and in differentiating human eosinophils derived from CD34(+) hematopoietic progenitors. Likewise, overexpression of GATA-2 in resulted in augmented transcription of both EDN/RNase2 and GATA-1. Taken together, our data suggest that GATA-2 functions directly via interactions with the EDN promoter and also indirectly, via its ability to regulate the expression of GATA-1 in differentiating eosinophils (Qiu et al. J Biol Chem. 2009).
Another publication focuses on the diversity of mammalian RNase A ribonucleases, and completes some outstanding work from Dr. Wei Zhao's visiting professorship with our group. This manuscript, which identifies a novel cluster of rodent RNase 1 genes, serves also to complete and to correct several erroneous entries in GenBank database (Siegel et al. Mamm Genome, 2009, in press)
I continue to serve on the Editorial Board of Journal of Biological Chemistry (since 2008), a largely due to my expertise in Ribonuclease Biology and Biochemistry.
在本报告期间,我们研究了 GATA-1 和 GATA-2 在激活分泌性核糖核酸酶(嗜酸性粒细胞衍生的神经毒素 (EDN/RNase 2))转录中的作用。 在嗜酸性粒细胞中检测到 GATA-1 和 GATA-2 表达增强,EDN/RNase2 基因延伸 5' 启动子中两个共有 GATA 结合位点之一或两者的缺失或突变导致报告基因活性大幅降低。抗体增强的电泳迁移率变化和染色质免疫沉淀分析表明,GATA-1 和 GATA-2 蛋白与 EDN 启动子中的两个功能性 GATA 共有序列结合。有趣的是,单独 GATA-1 的 RNA 沉默对 EDN/RNase2 表达没有影响; GATA-2的沉默导致丁酸诱导的HL-60克隆15细胞和来自CD34(+)造血祖细胞的分化人嗜酸性粒细胞中EDN表达减少,并且GATA-1表达减少。同样,GATA-2 的过度表达导致 EDN/RNase2 和 GATA-1 的转录增强。总而言之,我们的数据表明,GATA-2 通过与 EDN 启动子相互作用直接发挥作用,也通过其在分化嗜酸性粒细胞中调节 GATA-1 表达的能力间接发挥作用 (Qiu 等人,J Biol Chem. 2009)。
另一篇出版物重点关注哺乳动物RNase A核糖核酸酶的多样性,并完成了赵伟博士在我们课题组客座教授期间的一些杰出工作。 这份手稿鉴定了啮齿动物 RNase 1 基因的一个新簇,也用于完成和纠正 GenBank 数据库中的几个错误条目(Siegel 等人 Mamm Genome,2009 年,出版中)
我继续担任 Journal of Biological Chemistry 编辑委员会成员(自 2008 年起),这很大程度上归功于我在核糖核酸酶生物学和生物化学方面的专业知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HELENE ROSENBERG其他文献
HELENE ROSENBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HELENE ROSENBERG', 18)}}的其他基金
CARDIOTOXICITY OF EOSINOPHIL GRANULE CATIONIC PROTEINS
嗜酸性粒细胞颗粒阳离子蛋白的心脏毒性
- 批准号:
3087626 - 财政年份:1989
- 资助金额:
$ 42.3万 - 项目类别:
CARDIOTOXICITY OF EOSINOPHIL GRANULE CATIONIC PROTEINS
嗜酸性粒细胞颗粒阳离子蛋白的心脏毒性
- 批准号:
3087628 - 财政年份:1989
- 资助金额:
$ 42.3万 - 项目类别:
CARDIOTOXICITY OF EOSINOPHIL GRANULE CATIONIC PROTEINS
嗜酸性粒细胞颗粒阳离子蛋白的心脏毒性
- 批准号:
3087627 - 财政年份:1989
- 资助金额:
$ 42.3万 - 项目类别:
Inflammation and Therapy for Respiratory Virus Infection
呼吸道病毒感染的炎症和治疗
- 批准号:
7006273 - 财政年份:
- 资助金额:
$ 42.3万 - 项目类别:
Inflammation and Therapy for Respiratory Virus Infection
呼吸道病毒感染的炎症和治疗
- 批准号:
8745415 - 财政年份:
- 资助金额:
$ 42.3万 - 项目类别:
Molecular Biology of the Ribonuclease A Gene Superfamily
核糖核酸酶 A 基因超家族的分子生物学
- 批准号:
7732597 - 财政年份:
- 资助金额:
$ 42.3万 - 项目类别:
Inflammation and Therapy for Respiratory Virus Infection
呼吸道病毒感染的炎症和治疗
- 批准号:
10272105 - 财政年份:
- 资助金额:
$ 42.3万 - 项目类别:
Molecular Biology of the Ribonuclease A Gene Superfamily
核糖核酸酶 A 基因超家族的分子生物学
- 批准号:
7196724 - 财政年份:
- 资助金额:
$ 42.3万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 42.3万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 42.3万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 42.3万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 42.3万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 42.3万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 42.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 42.3万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 42.3万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 42.3万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 42.3万 - 项目类别:














{{item.name}}会员




